back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:24 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
150,000 | |
| Filed 2025-03-20 12:23 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
250,000 | |
| Filed 2025-03-20 12:22 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
0 | |
| Filed 2024-12-10 13:56 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,500 vol |
212,500 | |
| Filed 2024-12-10 13:55 Tx date 2024-12-09 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-37,500 vol |
37,500 | |
| Filed 2024-12-02 19:19 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,000 vol |
175,000 | |
| Filed 2024-12-02 19:19 Tx date 2024-11-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-75,000 vol |
75,000 | |
| Filed 2024-03-01 14:04 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-01 13:30 Tx date 2021-06-18 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-10 15:19 Tx date 2023-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,000
+100,000 vol $0.05 each |
100,000 | |
| Filed 2023-05-10 15:18 Tx date 2021-06-18 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-10 15:18 Tx date 2023-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
50,000 |